References
Original article
Smith, M. R. et al. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. New Engl. J. Med. https://doi.org/10.1056/NEJMoa2119115 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fenner, A. Darolutamide combo is a sensible option for mHSPC. Nat Rev Clin Oncol 19, 219 (2022). https://doi.org/10.1038/s41571-022-00616-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00616-2
- Springer Nature Limited